27
https://pubmed.ncbi.nlm.nih.gov/38091717
A series of 1,2,4-oxadiazole based non-steroidal derivatives were synthesized and found to exhibit potent anti-prostate cancer activity, with compound SP04 showing significant decrease in cell viability and inhibition of androgen receptor expression.
